Venus Medtech (Hangzhou), Inc. Class H (HK:2500) has released an update.
Don't Miss out on Research Tools:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Venus Medtech (Hangzhou) Inc. has announced its 2024 Second Extraordinary General Meeting, set to take place on December 5, 2024. Key resolutions include the election of Mr. John Junhua Gu as an independent non-executive director and proposed amendments to the company’s Articles of Association. Shareholders are encouraged to participate and vote on these significant decisions.
For further insights into HK:2500 stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Boeing (NYSE:BA) Layoffs Expand, Start Hitting Multiple Factories
- Microsoft’s (NASDAQ:MSFT) New Computer is Exclusively a Cloud Machine
- Walmart (NYSE:WMT) Warns About Tariff-Driven Price Hikes
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
